Epidemiology of vasopressin use for adults with septic shock

Annals of the American Thoracic Society

Volumn 13, Issue 10, 2016, Pages 1760-1767

  Vail, Emily A ^a   Gershengorn, Hayley B ^b,c   Hua, May ^a   Walkey, Allan J ^d   Wunsch, Hannah ^e,f  

^a Columbia University ^*  (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d BOSTON UNIVERSITY   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Practice variation; Septic shock; Vasoconstrictor agents

Indexed keywords

AMRINONE; DOBUTAMINE; DOPAMINE; EPINEPHRINE; MILRINONE; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN; VASOCONSTRICTOR AGENT; VASOPRESSIN DERIVATIVE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH CARE; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL CHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEPTIC SHOCK; CLINICAL TRIAL; COMBINATION DRUG THERAPY; COMPLICATION; DRUG UTILIZATION; FACTUAL DATABASE; HOSPITAL; HYPOTENSION; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AGED; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HOSPITALS; HUMANS; HYPOTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; UNITED STATES; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84992665702     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201604-259OC     Document Type: Article

References (39)

1. Russell JA. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 2011;15:226.
2. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-1282.
3. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-1125.
4. Serpa Neto A, Nassar AP, Cardoso SO, Manetta JA, Pereira VG, Espó sito DC, Damasceno MC, Russell JA. Vasopressin and terlipressin in adult vasodilatory shock: A systematic review and meta-analysis of nine randomized controlled trials. Crit Care 2012; 16:R154.
5. Polito A, Parisini E, Ricci Z, Picardo S, Annane D. Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med 2012;38:9-19.
6. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999;47:699-703. [Discussion, pp. 703-705].
7. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-582.
8. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, et al. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): A randomized, controlled pilot study. Crit Care 2009;13: R130.
9. Lauzier F, Lévy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: A randomized clinical trial. Intensive Care Med 2006;32:1782-1789.
10. Luckner G, Dünser MW, Jochberger S, Mayr VD, Wenzel V, Ulmer H, Schmid S, Knotzer H, Pajk W, Hasibeder W, et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005;33:2659-2666.
11. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al.; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.
12. Narat S, Thongprayoon C, Kittanamongkolchai W, Cheungpasitporn W, Erdogan A, Carrera P, Kashanie K. [Abstract] Changing trends in the use of vasopressors in intensive care unit: A 7-year study [abstract]. Crit Care Med 2014;42:A1450.
13. Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) study. Crit Care Med 2006;34:589-597.
14. Beck V, Chateau D, Bryson GL, Pisipati A, Zanotti S, Parrillo JE, Kumar A; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Timing of vasopressor initiation and mortality in septic shock: A cohort study. Crit Care 2014;18:R97.
15. Fawzy A, Evans SR, Walkey AJ. Practice patterns and outcomes associated with choice of initial vasopressor therapy for septic shock. Crit Care Med 2015;43:2141-2146.
16. Vail E, Gershengorn HB, Li G, Wunsch H. Epidemiology of vasopressor use among adults with septic shock in the United States [abstract]. Presented at the American Society of Anesthesiologists' Annual Meeting. October 27, 2015, San Diego, CA. Abstract A4014.
17. Vail E, Gershengorn HB, Hua M, Walkey AJ, Wunsch H. Epidemiology of vasopressin use among adults with septic shock in the United States [abstract]. Am J Respir Crit Care Med 2016;193:A6148.
18. About Premier healthcare database. 2015 [accessed 2016 Jan 24]. Available from: http://www.premierinc.com/transforming-healthcare/healthcare-performance-improvement/premier-research-services/
19. Herzig SJ, Rothberg MB, Guess JR, Gurwitz JH, Marcantonio ER. Antipsychotic medication utilization in nonpsychiatric hospitalizations. J Hosp Med 2016;11:543-549.
20. Hauptman PJ, Blume SW, Lewis EF, Ward S. Digoxin toxicity and use of digoxin immune fab: insights from a national hospital database. JACC Heart Fail 2016;4:357-364.
21. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310.
22. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
23. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
24. Fawzy A, Bradford M, Lindenauer PK, Walkey AJ. Identifying vasopressor and inotrope use for health services research. Ann Am Thorac Soc 2016;13:414-418.
25. Healthcare Cost and Utilization Project. HCUP Procedure Classes. 2014 [accessed 2015 Aug 31]. Available from: http://www.hcup-us. ahrq.gov/toolssoftware/procedure/procedure.jsp
26. Ehlenbach WJ, Barnato AE, Curtis JR, Kreuter W, Koepsell TD, Deyo RA, Stapleton RD. Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly. N Engl J Med 2009;361: 22-31.
27. Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Iwai S, Jain D, Sule S, Ahmed A, et al. Regional variation in the incidence and outcomes of in-hospital cardiac arrest in the United States. Circulation 2015;131:1415-1425.
28. Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, Ra stam L, Larsen K. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health 2006;60:290-297.
29. Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag; 2001.
30. Gershengorn HB, Garland A, Kramer A, Scales DC, Rubenfeld G, Wunsch H. Variation of arterial and central venous catheter use in United States intensive care units. Anesthesiology 2014;120: 650-664.
31. Gordon AC, Wang N, Walley KR, Ashby D, Russell JA. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock. Chest 2012;142:593-605.
32. Hernandez AF, Li S, Dokholyan RS, O'Brien SM, Ferguson TB, Peterson ED. Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. Am Heart J 2009;158:47-52.
33. Bennett-Guerrero E, Zhao Y, O'Brien SM, Ferguson TB Jr, Peterson ED, Gammie JS, Song HK. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010;304:1568-1575.
34. Russell JA, Walley KR, Singer J, Gordon AC, Hé bert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, et al.; VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887.
35. De Backer D, Aldecoa C, Njimi H, Vincent JL. Dopamine versus norepinephrine in the treatment of septic shock: A meta-analysis. Crit Care Med 2012;40:725-730.
36. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010;362:779-789.
37. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al.; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
38. Iwashyna TJ, Odden A, Rohde J, Bonham C, Kuhn L, Malani P, Chen L, Flanders S. Identifying patients with severe sepsis using administrative claims: patient-level validation of the angus implementation of the international consensus conference definition of severe sepsis. Med Care 2014;52:e39-e43.
39. Cooke CR, Iwashyna TJ. Using existing data to address important clinical questions in critical care. Crit Care Med 2013;41:886-896.